Related by context. Frequent words. (Click for all words.) 77 Release Tablets 75 Generic Version 73 FDA Accepts 71 Receives Orphan Drug Designation 71 Phase III Clinical Trial 71 Meets Primary Endpoint 70 Pivotal Phase III 70 Extended Release Tablets 70 Phase III Trial 70 gets USFDA nod 70 FDA Clears 69 Patient Enrollment 69 injection USP 69 Presents Positive 69 Initiates Phase II 68 Completes Enrollment 68 Delayed Release 68 Extended Release 67 Positive Opinion 67 Sumatriptan 67 Drug Application 67 Oral Solution 67 Aloxi R 67 Drug Candidate 67 Kuvan R 67 Single Dose 67 THALOMID 67 Transcept Pharmaceuticals 66 Announces FDA Clearance 66 FDA Approves 66 Clinical Trial Results 65 BioGlue R 65 Ticagrelor 65 ZEGERID Capsules 65 Pivotal Trial 65 DRRX 65 Inc Therapeutic Competitors 65 Pravastatin 65 ABILIFY R 65 #mg #mg [002] 65 Receives FDA Clearance 65 Pivotal Study 65 ISTA Pharmaceuticals 65 AMRIX 64 Frova R 64 Full Prescribing Information 64 VALSTAR 64 Advancing Drugs 64 ZYFLO CR 64 rosuvastatin calcium 64 Application MAA 64 Eloxatin ® 64 Ranexa R 64 Valsartan 64 Significantly Improves 64 Inc. Nasdaq SEPR 63 Hydrochloride 63 Aradigm Corporation 63 BioDelivery Sciences 63 Ambrisentan 63 Teva Pharma 63 ZALBIN 63 Pivotal Phase 63 LIALDA 63 FDA Clearance 63 NEBIDO R 63 Pulmonary Arterial Hypertension 63 Receives CE 63 application sNDA 63 FDA Approval 63 Drug Submission 63 GlaxoSmithKline plc GSK 63 Pirfenidone 63 Ixempra 63 Significantly Reduces 63 Recombinant Human 63 Testim R 63 sodium phosphate monobasic monohydrate 63 Argatroban 63 Rebif ® 62 Commences Phase 62 Initiate Phase 62 refractory chronic lymphocytic 62 NASDAQ SHPGY 62 CoTherix Inc. 62 CRME 62 Zyflo 62 Acute Ischemic Stroke 62 Application BLA 62 Anti Inflammatory 62 Study Demonstrates 62 Irinotecan 62 Pennsaid R 62 NASDAQ SLXP 62 Levofloxacin 62 PhosLo 62 Zytiga 62 Sanctura 62 alvimopan 62 BPAX 62 Injection USP